AU2021243864A1 - Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy - Google Patents

Info

Publication number

AU2021243864A1

AU2021243864A1 AU2021243864A AU2021243864A AU2021243864A1 AU 2021243864 A1 AU2021243864 A1 AU 2021243864A1 AU 2021243864 A AU2021243864 A AU 2021243864A AU 2021243864 A AU2021243864 A AU 2021243864A AU 2021243864 A1 AU2021243864 A1 AU 2021243864A1

Authority

AU

Australia

Prior art keywords

cells

cell

antigen

tumor

modified

Prior art date

2020-03-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 238000011467 adoptive cell therapy Methods 0.000 title description 19
• 230000002708 enhancing effect Effects 0.000 title description 3
• 210000004027 cell Anatomy 0.000 claims description 618
• 239000000427 antigen Substances 0.000 claims description 505
• 108091007433 antigens Proteins 0.000 claims description 505
• 102000036639 antigens Human genes 0.000 claims description 505
• 206010028980 Neoplasm Diseases 0.000 claims description 337
• 238000000034 method Methods 0.000 claims description 291
• 108091008874 T cell receptors Proteins 0.000 claims description 280
• 210000002865 immune cell Anatomy 0.000 claims description 266
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 261
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 222
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 145
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 117
• 230000027455 binding Effects 0.000 claims description 78
• 108090000623 proteins and genes Proteins 0.000 claims description 73
• 102000027596 immune receptors Human genes 0.000 claims description 71
• 108091008915 immune receptors Proteins 0.000 claims description 71
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 58
• 239000000203 mixture Substances 0.000 claims description 46
• 201000011510 cancer Diseases 0.000 claims description 45
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 44
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 44
• 102000004169 proteins and genes Human genes 0.000 claims description 43
• 241000282414 Homo sapiens Species 0.000 claims description 42
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 42
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 42
• 230000004068 intracellular signaling Effects 0.000 claims description 42
• 201000010099 disease Diseases 0.000 claims description 41
• 238000012258 culturing Methods 0.000 claims description 39
• 210000004443 dendritic cell Anatomy 0.000 claims description 39
• 230000004913 activation Effects 0.000 claims description 38
• 150000001413 amino acids Chemical group 0.000 claims description 36
• 108010033276 Peptide Fragments Proteins 0.000 claims description 35
• 102000007079 Peptide Fragments Human genes 0.000 claims description 35
• 230000000139 costimulatory effect Effects 0.000 claims description 34
• 210000003071 memory t lymphocyte Anatomy 0.000 claims description 34
• 230000003834 intracellular effect Effects 0.000 claims description 31
• 125000003729 nucleotide group Chemical group 0.000 claims description 30
• 239000002773 nucleotide Substances 0.000 claims description 29
• 230000035755 proliferation Effects 0.000 claims description 29
• 210000004881 tumor cell Anatomy 0.000 claims description 26
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 claims description 24
• 102100035793 CD83 antigen Human genes 0.000 claims description 24
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims description 24
• 239000012634 fragment Substances 0.000 claims description 24
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 23
• 230000011664 signaling Effects 0.000 claims description 23
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 22
• 101150013553 CD40 gene Proteins 0.000 claims description 21
• 102100025221 CD70 antigen Human genes 0.000 claims description 21
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 21
• -1 ICOS (CD278) Proteins 0.000 claims description 21
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 21
• 230000002062 proliferating effect Effects 0.000 claims description 19
• 230000004077 genetic alteration Effects 0.000 claims description 18
• 208000035475 disorder Diseases 0.000 claims description 17
• 230000004936 stimulating effect Effects 0.000 claims description 17
• 230000003612 virological effect Effects 0.000 claims description 17
• 241000701022 Cytomegalovirus Species 0.000 claims description 16
• 230000000638 stimulation Effects 0.000 claims description 16
• 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 claims description 14
• 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 13
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 13
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 13
• 229960005486 vaccine Drugs 0.000 claims description 13
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 12
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims description 12
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 12
• 101000621309 Homo sapiens Wilms tumor protein Proteins 0.000 claims description 12
• 102100022748 Wilms tumor protein Human genes 0.000 claims description 12
• 230000003213 activating effect Effects 0.000 claims description 11
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims description 10
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 9
• 102100027735 Hyaluronan mediated motility receptor Human genes 0.000 claims description 9
• 108010043610 KIR Receptors Proteins 0.000 claims description 9
• 102000002698 KIR Receptors Human genes 0.000 claims description 9
• 108010008707 Mucin-1 Proteins 0.000 claims description 9
• 102100034256 Mucin-1 Human genes 0.000 claims description 9
• 108060006580 PRAME Proteins 0.000 claims description 9
• 102000036673 PRAME Human genes 0.000 claims description 9
• 108010003425 hyaluronan-mediated motility receptor Proteins 0.000 claims description 9
• 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims description 8
• 102100028681 C-type lectin domain family 4 member K Human genes 0.000 claims description 8
• 101710183165 C-type lectin domain family 4 member K Proteins 0.000 claims description 8
• 102100027207 CD27 antigen Human genes 0.000 claims description 8
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 8
• 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 claims description 8
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 claims description 8
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 8
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 8
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 8
• 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 claims description 8
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 8
• 108010002687 Survivin Proteins 0.000 claims description 8
• 102100037906 T-cell surface glycoprotein CD3 zeta chain Human genes 0.000 claims description 8
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 8
• 239000002458 cell surface marker Substances 0.000 claims description 8
• 210000000349 chromosome Anatomy 0.000 claims description 8
• 210000005220 cytoplasmic tail Anatomy 0.000 claims description 8
• 230000001965 increasing effect Effects 0.000 claims description 8
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 8
• 102100038078 CD276 antigen Human genes 0.000 claims description 7
• 101710185679 CD276 antigen Proteins 0.000 claims description 7
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 claims description 7
• 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 7
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 7
• 230000000259 anti-tumor effect Effects 0.000 claims description 7
• 230000001086 cytosolic effect Effects 0.000 claims description 7
• 230000001939 inductive effect Effects 0.000 claims description 7
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 6
• 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 6
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 6
• 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims description 6
• 230000001580 bacterial effect Effects 0.000 claims description 6
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims description 5
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 5
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 5
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims description 5
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 5
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 5
• 239000013566 allergen Substances 0.000 claims description 5
• 239000003053 toxin Substances 0.000 claims description 5
• 231100000765 toxin Toxicity 0.000 claims description 5
• 108700012359 toxins Proteins 0.000 claims description 5
• 231100000611 venom Toxicity 0.000 claims description 5
• 239000002435 venom Substances 0.000 claims description 5
• 210000001048 venom Anatomy 0.000 claims description 5
• 102100032937 CD40 ligand Human genes 0.000 claims description 4
• 102000016607 Diphtheria Toxin Human genes 0.000 claims description 4
• 108010053187 Diphtheria Toxin Proteins 0.000 claims description 4
• 101000738335 Homo sapiens T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 claims description 4
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims description 4
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims description 4
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 4
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims description 4
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 4
• 230000002538 fungal effect Effects 0.000 claims description 4
• 239000007788 liquid Substances 0.000 claims description 4
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 4
• 102100037904 CD9 antigen Human genes 0.000 claims description 3
• 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 claims description 3
• 108010087819 Fc receptors Proteins 0.000 claims description 3
• 102000009109 Fc receptors Human genes 0.000 claims description 3
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims description 3
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 claims description 3
• 101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 claims description 3
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims description 3
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 3
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 3
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 3
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 3
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 3
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims description 3
• 102100025390 Integrin beta-2 Human genes 0.000 claims description 3
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 3
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 3
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 3
• 102000007399 Nuclear hormone receptor Human genes 0.000 claims description 3
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 3
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 3
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 3
• 108091005906 Type I transmembrane proteins Proteins 0.000 claims description 3
• 108091007930 cytoplasmic receptors Proteins 0.000 claims description 3
• 230000001747 exhibiting effect Effects 0.000 claims description 3
• 230000002209 hydrophobic effect Effects 0.000 claims description 3
• 231100000252 nontoxic Toxicity 0.000 claims description 3
• 230000003000 nontoxic effect Effects 0.000 claims description 3
• 230000007704 transition Effects 0.000 claims description 3
• 101100044298 Drosophila melanogaster fand gene Proteins 0.000 claims description 2
• 101150064015 FAS gene Proteins 0.000 claims description 2
• 101150028321 Lck gene Proteins 0.000 claims description 2
• 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 claims description 2
• 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 2
• 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims description 2
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims description 2
• 239000006166 lysate Substances 0.000 claims description 2
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 113
• 229920001184 polypeptide Polymers 0.000 description 100
• 150000007523 nucleic acids Chemical class 0.000 description 66
• 102000039446 nucleic acids Human genes 0.000 description 61
• 108020004707 nucleic acids Proteins 0.000 description 61
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 46
• 230000000890 antigenic effect Effects 0.000 description 44
• 230000001976 improved effect Effects 0.000 description 42
• 230000028993 immune response Effects 0.000 description 41
• 235000001014 amino acid Nutrition 0.000 description 37
• 235000018102 proteins Nutrition 0.000 description 36
• 229940024606 amino acid Drugs 0.000 description 35
• 239000013598 vector Substances 0.000 description 30
• 238000012384 transportation and delivery Methods 0.000 description 28
• 108020004414 DNA Proteins 0.000 description 26
• 230000014509 gene expression Effects 0.000 description 26
• 238000002255 vaccination Methods 0.000 description 25
• 230000002163 immunogen Effects 0.000 description 24
• 238000000338 in vitro Methods 0.000 description 24
• 230000002601 intratumoral effect Effects 0.000 description 24
• 230000004044 response Effects 0.000 description 23
• 239000013604 expression vector Substances 0.000 description 22
• 230000006870 function Effects 0.000 description 20
• 239000003446 ligand Substances 0.000 description 19
• 238000003752 polymerase chain reaction Methods 0.000 description 19
• 230000009258 tissue cross reactivity Effects 0.000 description 19
• 238000011282 treatment Methods 0.000 description 18
• 108020004999 messenger RNA Proteins 0.000 description 17
• 210000001519 tissue Anatomy 0.000 description 17
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 16
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 description 15
• 238000004520 electroporation Methods 0.000 description 15
• 125000003275 alpha amino acid group Chemical group 0.000 description 14
• 108020003589 5' Untranslated Regions Proteins 0.000 description 13
• 239000012636 effector Substances 0.000 description 13
• 230000015654 memory Effects 0.000 description 13
• 102000005962 receptors Human genes 0.000 description 13
• 108020003175 receptors Proteins 0.000 description 13
• 230000009870 specific binding Effects 0.000 description 13
• 238000013518 transcription Methods 0.000 description 13
• 230000035897 transcription Effects 0.000 description 13
• 241001465754 Metazoa Species 0.000 description 12
• 101100054855 Mus musculus Adam11 gene Proteins 0.000 description 12
• 206010033128 Ovarian cancer Diseases 0.000 description 12
• 210000000182 cd11c+cd123- dc Anatomy 0.000 description 12
• 238000002659 cell therapy Methods 0.000 description 12
• 108020005345 3' Untranslated Regions Proteins 0.000 description 11
• 241000700605 Viruses Species 0.000 description 11
• 150000002632 lipids Chemical class 0.000 description 11
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 10
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 10
• 210000000612 antigen-presenting cell Anatomy 0.000 description 10
• 230000003993 interaction Effects 0.000 description 10
• 238000011068 loading method Methods 0.000 description 10
• 239000003504 photosensitizing agent Substances 0.000 description 10
• 201000009030 Carcinoma Diseases 0.000 description 9
• 206010061535 Ovarian neoplasm Diseases 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 9
• 210000000987 immune system Anatomy 0.000 description 9
• 108091033319 polynucleotide Proteins 0.000 description 9
• 102000040430 polynucleotide Human genes 0.000 description 9
• 239000002157 polynucleotide Substances 0.000 description 9
• 238000013519 translation Methods 0.000 description 9
• 239000003981 vehicle Substances 0.000 description 9
• 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 description 8
• 102000004127 Cytokines Human genes 0.000 description 8
• 108090000695 Cytokines Proteins 0.000 description 8
• 108060003951 Immunoglobulin Proteins 0.000 description 8
• 241000713666 Lentivirus Species 0.000 description 8
• 206010039491 Sarcoma Diseases 0.000 description 8
• 230000006052 T cell proliferation Effects 0.000 description 8
• 210000003719 b-lymphocyte Anatomy 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 210000000172 cytosol Anatomy 0.000 description 8
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 8
• 102000018358 immunoglobulin Human genes 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• 239000012528 membrane Substances 0.000 description 8
• 208000008443 pancreatic carcinoma Diseases 0.000 description 8
• 239000013612 plasmid Substances 0.000 description 8
• 229920000642 polymer Polymers 0.000 description 8
• 230000004083 survival effect Effects 0.000 description 8
• 230000001225 therapeutic effect Effects 0.000 description 8
• 238000001890 transfection Methods 0.000 description 8
• 241000701161 unidentified adenovirus Species 0.000 description 8
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 7
• 108091023045 Untranslated Region Proteins 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 210000000170 cell membrane Anatomy 0.000 description 7
• 230000000295 complement effect Effects 0.000 description 7
• 230000036541 health Effects 0.000 description 7
• 230000036039 immunity Effects 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 239000002502 liposome Substances 0.000 description 7
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 7
• 238000004519 manufacturing process Methods 0.000 description 7
• 201000002528 pancreatic cancer Diseases 0.000 description 7
• 239000002243 precursor Substances 0.000 description 7
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 6
• 101710187864 TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 6
• 239000002671 adjuvant Substances 0.000 description 6
• 230000000735 allogeneic effect Effects 0.000 description 6
• 230000037396 body weight Effects 0.000 description 6
• 235000018417 cysteine Nutrition 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 208000032839 leukemia Diseases 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 210000000822 natural killer cell Anatomy 0.000 description 6
• 210000005259 peripheral blood Anatomy 0.000 description 6
• 239000011886 peripheral blood Substances 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 241000894007 species Species 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 229940124597 therapeutic agent Drugs 0.000 description 6
• 238000002560 therapeutic procedure Methods 0.000 description 6
• 238000012546 transfer Methods 0.000 description 6
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
• 101710095183 B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 5
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 5
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 5
• 108091054437 MHC class I family Proteins 0.000 description 5
• 108091054438 MHC class II family Proteins 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 108091036407 Polyadenylation Proteins 0.000 description 5
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 5
• 230000006044 T cell activation Effects 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 230000004663 cell proliferation Effects 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 5
• 238000006471 dimerization reaction Methods 0.000 description 5
• 238000009169 immunotherapy Methods 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 238000003780 insertion Methods 0.000 description 5
• 230000037431 insertion Effects 0.000 description 5
• 230000010354 integration Effects 0.000 description 5
• 210000002540 macrophage Anatomy 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 210000001806 memory b lymphocyte Anatomy 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 230000019491 signal transduction Effects 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 238000010361 transduction Methods 0.000 description 5
• 230000026683 transduction Effects 0.000 description 5
• 241001430294 unidentified retrovirus Species 0.000 description 5
• 239000013603 viral vector Substances 0.000 description 5
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
• 108091008048 CMVpp65 Proteins 0.000 description 4
• 108091033380 Coding strand Proteins 0.000 description 4
• 241000702421 Dependoparvovirus Species 0.000 description 4
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 4
• 102000043129 MHC class I family Human genes 0.000 description 4
• 102000043131 MHC class II family Human genes 0.000 description 4
• 108091034057 RNA (poly(A)) Proteins 0.000 description 4
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 description 4
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 4
• 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 4
• 102100027010 Toll-like receptor 1 Human genes 0.000 description 4
• 108010060889 Toll-like receptor 1 Proteins 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 150000001945 cysteines Chemical class 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 239000012645 endogenous antigen Substances 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 238000012239 gene modification Methods 0.000 description 4
• 238000001415 gene therapy Methods 0.000 description 4
• 230000005017 genetic modification Effects 0.000 description 4
• 235000013617 genetically modified food Nutrition 0.000 description 4
• 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 4
• 239000000833 heterodimer Substances 0.000 description 4
• 230000006054 immunological memory Effects 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 238000001802 infusion Methods 0.000 description 4
• 238000001990 intravenous administration Methods 0.000 description 4
• 244000309459 oncolytic virus Species 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 230000001177 retroviral effect Effects 0.000 description 4
• 239000000523 sample Substances 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 230000035899 viability Effects 0.000 description 4
• 102100023990 60S ribosomal protein L17 Human genes 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 102100024263 CD160 antigen Human genes 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 102100022132 High affinity immunoglobulin epsilon receptor subunit gamma Human genes 0.000 description 3
• 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 3
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 3
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 3
• 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 description 3
• 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 3
• 241000725303 Human immunodeficiency virus Species 0.000 description 3
• 108010073816 IgE Receptors Proteins 0.000 description 3
• 102000009438 IgE Receptors Human genes 0.000 description 3
• 102100032818 Integrin alpha-4 Human genes 0.000 description 3
• 102100032816 Integrin alpha-6 Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 3
• 206010025323 Lymphomas Diseases 0.000 description 3
• 241000542855 Megathura crenulata Species 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 102100029197 SLAM family member 6 Human genes 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 241000713311 Simian immunodeficiency virus Species 0.000 description 3
• 230000005867 T cell response Effects 0.000 description 3
• 101710146340 T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 3
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 3
• 230000003044 adaptive effect Effects 0.000 description 3
• 208000009956 adenocarcinoma Diseases 0.000 description 3
• 235000004279 alanine Nutrition 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 230000016396 cytokine production Effects 0.000 description 3
• 230000006378 damage Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• 208000005017 glioblastoma Diseases 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 230000021633 leukocyte mediated immunity Effects 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 238000001638 lipofection Methods 0.000 description 3
• 229920002521 macromolecule Polymers 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
• 210000000581 natural killer T-cell Anatomy 0.000 description 3
• 201000008968 osteosarcoma Diseases 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 230000002035 prolonged effect Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 239000013607 AAV vector Substances 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 108010074708 B7-H1 Antigen Proteins 0.000 description 2
• 206010004146 Basal cell carcinoma Diseases 0.000 description 2
• 206010004593 Bile duct cancer Diseases 0.000 description 2
• 206010005003 Bladder cancer Diseases 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 208000005243 Chondrosarcoma Diseases 0.000 description 2
• 208000006332 Choriocarcinoma Diseases 0.000 description 2
• PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 2
• 108010060123 Conjugate Vaccines Proteins 0.000 description 2
• 206010011831 Cytomegalovirus infection Diseases 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 208000006168 Ewing Sarcoma Diseases 0.000 description 2
• 201000008808 Fibrosarcoma Diseases 0.000 description 2
• 206010018338 Glioma Diseases 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 2
• 108091010847 High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 101100112778 Homo sapiens CD247 gene Proteins 0.000 description 2
• 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 description 2
• 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 2
• 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 2
• 101001035237 Homo sapiens Integrin alpha-D Proteins 0.000 description 2
• 101001046687 Homo sapiens Integrin alpha-E Proteins 0.000 description 2
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 2
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
• 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 2
• 101000971538 Homo sapiens Killer cell lectin-like receptor subfamily F member 1 Proteins 0.000 description 2
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 2
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 2
• 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 description 2
• 101000633780 Homo sapiens Signaling lymphocytic activation molecule Proteins 0.000 description 2
• 101100207070 Homo sapiens TNFSF8 gene Proteins 0.000 description 2
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 2
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 2
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 2
• 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 description 2
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 2
• 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 2
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
• 102100025323 Integrin alpha-1 Human genes 0.000 description 2
• 102100039904 Integrin alpha-D Human genes 0.000 description 2
• 102100022341 Integrin alpha-E Human genes 0.000 description 2
• 102100022297 Integrin alpha-X Human genes 0.000 description 2
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 2
• 108090000978 Interleukin-4 Proteins 0.000 description 2
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 2
• 102100021458 Killer cell lectin-like receptor subfamily F member 1 Human genes 0.000 description 2
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 208000018142 Leiomyosarcoma Diseases 0.000 description 2
• 239000000232 Lipid Bilayer Substances 0.000 description 2
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
• 208000007054 Medullary Carcinoma Diseases 0.000 description 2
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 206010027406 Mesothelioma Diseases 0.000 description 2
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 101100207071 Mus musculus Tnfsf8 gene Proteins 0.000 description 2
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 2
• 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 description 2
• 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 description 2
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 description 2
• 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 description 2
• 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 description 2
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 description 2
• 108010042215 OX40 Ligand Proteins 0.000 description 2
• 102000004473 OX40 Ligand Human genes 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 208000037581 Persistent Infection Diseases 0.000 description 2
• 108010047620 Phytohemagglutinins Proteins 0.000 description 2
• 101710124239 Poly(A) polymerase Proteins 0.000 description 2
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 2
• 206010060862 Prostate cancer Diseases 0.000 description 2
• 102000014128 RANK Ligand Human genes 0.000 description 2
• 108010025832 RANK Ligand Proteins 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 208000006265 Renal cell carcinoma Diseases 0.000 description 2
• 102100027744 Semaphorin-4D Human genes 0.000 description 2
• 201000010208 Seminoma Diseases 0.000 description 2
• 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 241000282887 Suidae Species 0.000 description 2
• 108050005496 T-cell surface glycoprotein CD3 delta chains Proteins 0.000 description 2
• 101710131569 T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 2
• 101710156660 T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 description 2
• 210000000662 T-lymphocyte subset Anatomy 0.000 description 2
• 210000000447 Th1 cell Anatomy 0.000 description 2
• 210000004241 Th2 cell Anatomy 0.000 description 2
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 2
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 2
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 2
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 2
• 102100039387 Toll-like receptor 6 Human genes 0.000 description 2
• 102100039390 Toll-like receptor 7 Human genes 0.000 description 2
• 102100033110 Toll-like receptor 8 Human genes 0.000 description 2
• 102100033117 Toll-like receptor 9 Human genes 0.000 description 2
• 108700019146 Transgenes Proteins 0.000 description 2
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 2
• 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 208000008383 Wilms tumor Diseases 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 239000012736 aqueous medium Substances 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 201000007180 bile duct carcinoma Diseases 0.000 description 2
• 239000012472 biological sample Substances 0.000 description 2
• 201000001531 bladder carcinoma Diseases 0.000 description 2
• 208000003362 bronchogenic carcinoma Diseases 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 230000005754 cellular signaling Effects 0.000 description 2
• 239000013626 chemical specie Substances 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 229940031670 conjugate vaccine Drugs 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000002716 delivery method Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 210000003162 effector t lymphocyte Anatomy 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 201000005787 hematologic cancer Diseases 0.000 description 2
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
• 230000013632 homeostatic process Effects 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 206010024627 liposarcoma Diseases 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 201000000050 myeloid neoplasm Diseases 0.000 description 2
• 208000001611 myxosarcoma Diseases 0.000 description 2
• 210000005170 neoplastic cell Anatomy 0.000 description 2
• 208000004019 papillary adenocarcinoma Diseases 0.000 description 2
• 201000010198 papillary carcinoma Diseases 0.000 description 2
• 230000002688 persistence Effects 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
• 150000003904 phospholipids Chemical class 0.000 description 2
• 230000001885 phytohemagglutinin Effects 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 210000003289 regulatory T cell Anatomy 0.000 description 2
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 230000002483 superagonistic effect Effects 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 201000010965 sweat gland carcinoma Diseases 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 206010042863 synovial sarcoma Diseases 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 230000001960 triggered effect Effects 0.000 description 2
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• KUHSEZKIEJYEHN-BXRBKJIMSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.OC[C@H](N)C(O)=O KUHSEZKIEJYEHN-BXRBKJIMSA-N 0.000 description 1
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
• 102000002627 4-1BB Ligand Human genes 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 1
• 108020005176 AU Rich Elements Proteins 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 201000003076 Angiosarcoma Diseases 0.000 description 1
• 102000006306 Antigen Receptors Human genes 0.000 description 1
• 108010083359 Antigen Receptors Proteins 0.000 description 1
• 108091023037 Aptamer Proteins 0.000 description 1
• 241000203069 Archaea Species 0.000 description 1
• 201000007848 Arts syndrome Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 208000004736 B-Cell Leukemia Diseases 0.000 description 1
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 206010006143 Brain stem glioma Diseases 0.000 description 1
• 108010056102 CD100 antigen Proteins 0.000 description 1
• 108010017009 CD11b Antigen Proteins 0.000 description 1
• 102100038077 CD226 antigen Human genes 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 108010062802 CD66 antigens Proteins 0.000 description 1
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
• 101100454808 Caenorhabditis elegans lgg-2 gene Proteins 0.000 description 1
• 101100217502 Caenorhabditis elegans lgg-3 gene Proteins 0.000 description 1
• 101100495352 Candida albicans CDR4 gene Proteins 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 1
• 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 102000001327 Chemokine CCL5 Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 108091062157 Cis-regulatory element Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 102100030886 Complement receptor type 1 Human genes 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 241000724252 Cucumber mosaic virus Species 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241000701867 Enterobacteria phage T7 Species 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000283074 Equus asinus Species 0.000 description 1
• 101000585551 Equus caballus Pregnancy-associated glycoprotein Proteins 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 102100031507 Fc receptor-like protein 5 Human genes 0.000 description 1
• 101710120217 Fc receptor-like protein 5 Proteins 0.000 description 1
• 241000713800 Feline immunodeficiency virus Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 102100022086 GRB2-related adapter protein 2 Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 241001663880 Gammaretrovirus Species 0.000 description 1
• 241000237858 Gastropoda Species 0.000 description 1
• 206010071602 Genetic polymorphism Diseases 0.000 description 1
• 208000000527 Germinoma Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 102000025850 HLA-A2 Antigen Human genes 0.000 description 1
• 108010074032 HLA-A2 Antigen Proteins 0.000 description 1
• 108010024164 HLA-G Antigens Proteins 0.000 description 1
• 208000001258 Hemangiosarcoma Diseases 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 101000884298 Homo sapiens CD226 antigen Proteins 0.000 description 1
• 101100112772 Homo sapiens CD3G gene Proteins 0.000 description 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101000900690 Homo sapiens GRB2-related adapter protein 2 Proteins 0.000 description 1
• 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 1
• 101000824104 Homo sapiens High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101001046683 Homo sapiens Integrin alpha-L Proteins 0.000 description 1
• 101001046668 Homo sapiens Integrin alpha-X Proteins 0.000 description 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
• 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 description 1
• 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 description 1
• 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
• 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 description 1
• 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 description 1
• 101001023379 Homo sapiens Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 1
• 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 description 1
• 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 description 1
• 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 description 1
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 1
• 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 description 1
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 1
• 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 1
• 101000821449 Homo sapiens Secreted and transmembrane protein 1 Proteins 0.000 description 1
• 101000662909 Homo sapiens T cell receptor beta constant 1 Proteins 0.000 description 1
• 101000662902 Homo sapiens T cell receptor beta constant 2 Proteins 0.000 description 1
• 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
• 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 1
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 1
• 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 101000648507 Homo sapiens Tumor necrosis factor receptor superfamily member 14 Proteins 0.000 description 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
• 101000679857 Homo sapiens Tumor necrosis factor receptor superfamily member 3 Proteins 0.000 description 1
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 description 1
• 101150003028 Hprt1 gene Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 241000714192 Human spumaretrovirus Species 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100023915 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000012330 Integrases Human genes 0.000 description 1
• 108010061833 Integrases Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 108010041100 Integrin alpha6 Proteins 0.000 description 1
• 108010030465 Integrin alpha6beta1 Proteins 0.000 description 1
• 102100025304 Integrin beta-1 Human genes 0.000 description 1
• 102100033016 Integrin beta-7 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 1
• 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 description 1
• 102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 1
• 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 description 1
• 108010091221 Lymphotoxin beta Receptor Proteins 0.000 description 1
• 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 1
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 1
• 208000037196 Medullary thyroid carcinoma Diseases 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 206010059282 Metastases to central nervous system Diseases 0.000 description 1
• 241000237852 Mollusca Species 0.000 description 1
• 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000711408 Murine respirovirus Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101100226902 Mus musculus Fcrlb gene Proteins 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 208000021320 Nasu-Hakola disease Diseases 0.000 description 1
• 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 description 1
• 101710141230 Natural killer cell receptor 2B4 Proteins 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 208000009905 Neurofibromatoses Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 108010058846 Ovalbumin Proteins 0.000 description 1
• 240000007019 Oxalis corniculata Species 0.000 description 1
• 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 206010033701 Papillary thyroid cancer Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108010065868 RNA polymerase SP6 Proteins 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 102100029216 SLAM family member 5 Human genes 0.000 description 1
• 102100029198 SLAM family member 7 Human genes 0.000 description 1
• 102100021853 Secreted and transmembrane protein 1 Human genes 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 102100037272 T cell receptor beta constant 1 Human genes 0.000 description 1
• 108010083312 T-Cell Antigen Receptor-CD3 Complex Proteins 0.000 description 1
• 101710085551 T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 1
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 108700012920 TNF Proteins 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 210000000068 Th17 cell Anatomy 0.000 description 1
• 210000002378 Th9 Anatomy 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 208000033781 Thyroid carcinoma Diseases 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 108010064978 Type II Site-Specific Deoxyribonucleases Proteins 0.000 description 1
• 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000014070 Vestibular schwannoma Diseases 0.000 description 1
• 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 description 1
• 108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 description 1
• 102000007624 ZAP-70 Protein-Tyrosine Kinase Human genes 0.000 description 1
• ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 208000004064 acoustic neuroma Diseases 0.000 description 1
• 230000006786 activation induced cell death Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 150000003838 adenosines Chemical class 0.000 description 1
• 208000020990 adrenal cortex carcinoma Diseases 0.000 description 1
• 208000007128 adrenocortical carcinoma Diseases 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 230000001270 agonistic effect Effects 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 230000003042 antagnostic effect Effects 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000005809 anti-tumor immunity Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 239000003012 bilayer membrane Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 201000008275 breast carcinoma Diseases 0.000 description 1
• 229960005520 bryostatin Drugs 0.000 description 1
• MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 description 1
• MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 description 1
• 230000000981 bystander Effects 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000003710 calcium ionophore Substances 0.000 description 1
• HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 1
• 208000035269 cancer or benign tumor Diseases 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 229920006317 cationic polymer Polymers 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000005859 cell recognition Effects 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 208000025997 central nervous system neoplasm Diseases 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 208000019065 cervical carcinoma Diseases 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 210000000991 chicken egg Anatomy 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 208000011654 childhood malignant neoplasm Diseases 0.000 description 1
• 208000012191 childhood neoplasm Diseases 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 238000001246 colloidal dispersion Methods 0.000 description 1
• 201000010989 colorectal carcinoma Diseases 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 239000000562 conjugate Substances 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 239000013256 coordination polymer Substances 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• 208000002445 cystadenocarcinoma Diseases 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 230000007402 cytotoxic response Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 229940093541 dicetylphosphate Drugs 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 230000000447 dimerizing effect Effects 0.000 description 1
• BPHQZTVXXXJVHI-UHFFFAOYSA-N dimyristoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCC BPHQZTVXXXJVHI-UHFFFAOYSA-N 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 1
• 201000007273 ductal carcinoma in situ Diseases 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 208000037828 epithelial carcinoma Diseases 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 201000005619 esophageal carcinoma Diseases 0.000 description 1
• CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 208000010749 gastric carcinoma Diseases 0.000 description 1
• 238000012215 gene cloning Methods 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 201000003115 germ cell cancer Diseases 0.000 description 1
• 150000002333 glycines Chemical class 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 201000002222 hemangioblastoma Diseases 0.000 description 1
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 230000003284 homeostatic effect Effects 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 230000008629 immune suppression Effects 0.000 description 1
• 230000006058 immune tolerance Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000002998 immunogenetic effect Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 238000000530 impalefection Methods 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 108091008042 inhibitory receptors Proteins 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000010468 interferon response Effects 0.000 description 1
• 230000031146 intracellular signal transduction Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
• 208000012804 lymphangiosarcoma Diseases 0.000 description 1
• 230000005291 magnetic effect Effects 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 230000006386 memory function Effects 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 239000010445 mica Substances 0.000 description 1
• 229910052618 mica group Inorganic materials 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 230000002297 mitogenic effect Effects 0.000 description 1
• 201000004058 mixed glioma Diseases 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 208000025189 neoplasm of testis Diseases 0.000 description 1
• 208000007538 neurilemmoma Diseases 0.000 description 1
• 201000004931 neurofibromatosis Diseases 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 210000004882 non-tumor cell Anatomy 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000002188 osteogenic effect Effects 0.000 description 1
• 229940092253 ovalbumin Drugs 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 230000003094 perturbing effect Effects 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 208000028591 pheochromocytoma Diseases 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 201000004123 pineal gland cancer Diseases 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 108010058237 plasma protein fraction Proteins 0.000 description 1
• 229940002993 plasmanate Drugs 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 208000031334 polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly Diseases 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 208000016800 primary central nervous system lymphoma Diseases 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000009696 proliferative response Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 238000002818 protein evolution Methods 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 102000037983 regulatory factors Human genes 0.000 description 1
• 108091008025 regulatory factors Proteins 0.000 description 1
• 230000008521 reorganization Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 208000001076 sarcopenia Diseases 0.000 description 1
• 206010039667 schwannoma Diseases 0.000 description 1
• 108091006024 signal transducing proteins Proteins 0.000 description 1
• 102000034285 signal transducing proteins Human genes 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 108091005475 signaling receptors Proteins 0.000 description 1
• 102000035025 signaling receptors Human genes 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 102000009076 src-Family Kinases Human genes 0.000 description 1
• 108010087686 src-Family Kinases Proteins 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 201000000498 stomach carcinoma Diseases 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 231100000617 superantigen Toxicity 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
• 208000013818 thyroid gland medullary carcinoma Diseases 0.000 description 1
• 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 206010044412 transitional cell carcinoma Diseases 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 208000012991 uterine carcinoma Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1